Stuart D. Cook

7.5k total citations · 1 hit paper
152 papers, 5.6k citations indexed

About

Stuart D. Cook is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Stuart D. Cook has authored 152 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pathology and Forensic Medicine, 35 papers in Neurology and 34 papers in Epidemiology. Recurrent topics in Stuart D. Cook's work include Multiple Sclerosis Research Studies (60 papers), Peripheral Neuropathies and Disorders (33 papers) and Virology and Viral Diseases (21 papers). Stuart D. Cook is often cited by papers focused on Multiple Sclerosis Research Studies (60 papers), Peripheral Neuropathies and Disorders (33 papers) and Virology and Viral Diseases (21 papers). Stuart D. Cook collaborates with scholars based in United States, United Kingdom and Germany. Stuart D. Cook's co-authors include Peter C. Dowling, Gavin Giovannoni, Patrick Vermersch, Gıancarlo Comı, Per Soelberg Sørensen, Peter Rieckmann, Kottil Rammohan, Anthony Hamlett, Steven J. Greenberg and Joseph Menonna and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Stuart D. Cook

149 papers receiving 5.4k citations

Hit Papers

A Placebo-Controlled Trial of Oral Cladribine for Relapsi... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart D. Cook United States 41 2.8k 1.5k 1.0k 840 811 152 5.6k
Jan Lycke Sweden 43 4.1k 1.5× 1.8k 1.2× 1.3k 1.3× 1.1k 1.3× 624 0.8× 148 6.3k
Martina Deckert Germany 45 2.5k 0.9× 2.3k 1.5× 854 0.8× 1.6k 1.9× 760 0.9× 150 6.4k
Tobias Derfuß Switzerland 41 3.2k 1.2× 1.7k 1.1× 1.1k 1.0× 2.0k 2.4× 850 1.0× 149 6.6k
Hillel Panitch United States 40 5.6k 2.0× 2.9k 1.9× 1.6k 1.5× 2.2k 2.6× 649 0.8× 95 8.3k
Thomas Leist United States 39 1.7k 0.6× 534 0.3× 860 0.8× 2.1k 2.5× 656 0.8× 124 4.9k
Allen J. Aksamit United States 38 977 0.4× 2.9k 1.9× 1.4k 1.4× 711 0.8× 1.2k 1.5× 99 7.4k
Jan D. Lünemann Germany 40 1.7k 0.6× 918 0.6× 1.0k 1.0× 2.3k 2.8× 1.0k 1.3× 127 5.5k
Ehud Lavi United States 46 761 0.3× 803 0.5× 660 0.6× 1.7k 2.1× 1.2k 1.5× 154 6.8k
Jürgen Haas Germany 39 1.4k 0.5× 752 0.5× 621 0.6× 1.8k 2.1× 880 1.1× 120 4.6k
Arthur Melms Germany 48 855 0.3× 4.7k 3.1× 683 0.7× 2.1k 2.6× 531 0.7× 146 8.5k

Countries citing papers authored by Stuart D. Cook

Since Specialization
Citations

This map shows the geographic impact of Stuart D. Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart D. Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart D. Cook more than expected).

Fields of papers citing papers by Stuart D. Cook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart D. Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart D. Cook. The network helps show where Stuart D. Cook may publish in the future.

Co-authorship network of co-authors of Stuart D. Cook

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart D. Cook. A scholar is included among the top collaborators of Stuart D. Cook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart D. Cook. Stuart D. Cook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giovannoni, Gavin, Per Soelberg Sørensen, Stuart D. Cook, et al.. (2017). Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study. Multiple Sclerosis Journal. 24(12). 1594–1604. 243 indexed citations
2.
Giovannoni, Gavin, Kottil Rammohan, Stuart D. Cook, et al.. (2017). Defining High Disease Activity (HDA) in Patients with Relapsing Multiple Sclerosis (RMS) Receiving Placebo in the CLARITY Study (P6.351). Neurology. 88(16_supplement). 2 indexed citations
3.
Maranzano, Josefina, David A. Rudko, Kunio Nakamura, et al.. (2017). MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis. Neurology. 89(7). 714–721. 13 indexed citations
5.
Schippling, Sven, Paul O’Connor, Volker Knappertz, et al.. (2016). Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial. Journal of Neurology. 263(7). 1418–1426. 38 indexed citations
6.
Brown, Robert A., Sridar Narayanan, Nikola Stikov, et al.. (2016). MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b. Neurology. 87(9). 905–911. 14 indexed citations
7.
Brown, Robert A., Stuart D. Cook, Diego Cadavid, et al.. (2013). Effect of Interferon beta-1b and Glatiramer Acetate on New MTR Brain Lesions in MS (P07.104). Neurology. 80(7_supplement). 1 indexed citations
8.
Goodin, Douglas S., George C. Ebers, Gary Cutter, et al.. (2012). Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study. BMJ Open. 2(6). e001972–e001972. 38 indexed citations
9.
Ali, Shehzad, Noman Paracha, Stuart D. Cook, et al.. (2011). Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis. Clinical Drug Investigation. 32(1). 15–27. 11 indexed citations
10.
Jaycock, Philip, Mark N. A. Jones, John Males, et al.. (2008). Outcomes of Same-Sizing versus Oversizing Donor Trephines in Keratoconic Patients Undergoing First Penetrating Keratoplasty. Ophthalmology. 115(2). 268–275. 24 indexed citations
11.
Cook, Stuart D., et al.. (2006). Delayed hypersensitivity following intravenous lidocaine. Contact Dermatitis. 54(4). 215–216. 3 indexed citations
12.
Li, Weiping, Yasuhiro Maeda, Rui Yuan, et al.. (2004). Beneficial effect of erythropoietin on experimental allergic encephalomyelitis. Annals of Neurology. 56(6). 767–777. 82 indexed citations
13.
Li, Weiping, Yasuhiro Maeda, Xue Ming, et al.. (2002). Apoptotic death following Fas activation in human oligodendrocyte hybrid cultures. Journal of Neuroscience Research. 69(2). 189–196. 25 indexed citations
14.
Cook, Stuart D.. (2001). Handbook of Multiple Sclerosis. 24 indexed citations
15.
Wolansky, Leo, et al.. (1998). Gadoteridol in multiple sclerosis patients. Clinical Imaging. 22(6). 385–392. 14 indexed citations
16.
Karabatsas, C.H., Stuart D. Cook, Kate Powell, & J M Sparrow. (1998). Comparison of Keratometry and Videokeratography After Penetrating Keratoplasty. Journal of Refractive Surgery. 14(4). 420–426. 9 indexed citations
17.
Cook, Stuart D., et al.. (1991). Handbook of Multiple Sclerosis. Annals of Internal Medicine. 115(7). 583–583. 127 indexed citations
18.
Lynas, Caroline, Stuart D. Cook, Keith A. Laycock, J W Bradfield, & Norman J. Maitland. (1989). Detection of latent virus mRNA in tissues using the polymerase chain reaction. The Journal of Pathology. 157(4). 285–289. 44 indexed citations
19.
Hirano, Asao, Stuart D. Cook, John N. Whitaker, Peter C. Dowling, & Margaret R. Murray. (1971). FINE STRUCTURAL ASPECTS OF DEMYELINATION IN VITRO. THE EFFECTS OF GUILLAIN-BARRÉ SERUM. Journal of Neuropathology & Experimental Neurology. 30(2). 249–265. 54 indexed citations
20.
Dowling, Peter C. & Stuart D. Cook. (1968). Pattern of cellular and humoral events in experimental allergic encephalomyelitis. Neurology. 18(10). 953–953. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026